J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bauer, P
Right arrow Articles by Riess, O
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bauer, P
Right arrow Articles by Riess, O
Journal of Medical Genetics 2004;41:230-232
© 2004 BMJ Publishing Group Ltd


LETTER TO JMG

Trinucleotide repeat expansion in SCA17/TBP in white patients with Huntington’s disease-like phenotype

P Bauer1, F Laccone2, A Rolfs3, U Wüllner4, S Bösch5, H Peters6, S Liebscher1, M Scheible1, J T Epplen7, B H F Weber8, E Holinski-Feder9, H Weirich-Schwaiger10, D J Morris-Rosendahl11, J Andrich12, O Riess1

1 Department of Medical Genetics, University of Tübingen, Germany
2 Department of Human Genetics, University of Göttingen, Germany
3 Department of Neurology, University of Rostock, Germany
4 Department of Neurology, University of Bonn, Germany
5 Department of Neurology, University of Innsbruck, Austria
6 Department of Medical Genetics, Charité, Humboldt University Berlin, Germany
7 Department of Human Genetics, Ruhr-University Bochum, Germany
8 Institute of Human Genetics, University of Würzburg, Germany
9 Medizinisch-Genetisches Zentrum, München, Germany
10 Institute of Medical Biology and Human Genetics, University of Innsbruck, Austria
11 Institute of Human Genetics and Anthropology, University of Freiburg, Germany
12 Department of Neurology, Ruhr-University Bochum, Germany

Correspondence to:
P Bauer
MD, University of Tübingen, Department of Medical Genetics, Calwerstrasse 7, D 72076 Tübingen, Germany; peter.bauer@med.uni-tuebingen.de] Received 17 October 2003
Revised version received 20 November 2003
21 November 2003

Keywords: Huntington’s disease-like; SCA17; TBP

Abbreviations: ADCA, autosomal dominant cerebellar ataxia; HD, Huntington’s disease; HD-like, Huntington’s disease-like; JPH3, Junctophilin-3 gene; PRNP, prion protein; SCA, spinocerebellar ataxia; TBP, TATA binding protein

The first 150 words of the full text of this article appear below.

Huntington’s disease (HD) is characterized by movement abnormalities and psychiatric symptoms. Prominent features include choreiform movements, dysarthria, ataxia, depression, dementia, and personality changes. The disease usually manifests during the third or fourth decade of live and progresses with dysphagia and subsequent cachexia causing death some 20 years later. Neuropathologically, the disease is characterized by atrophy of the caudate and putamen and, to a lesser extent, of the cortex, globus pallidum, thalamus, subthalamic region, and substantia nigra.1

A CAG repeat expansion in the HD gene resulting in an expanded polyglutamine chain in the huntingtin protein was identified as the major cause of HD.2 Phenocopies of HD have been described and designated as Huntington disease-like (HD-like). These disorders are genetically heterogeneous. In a consanguineous family of Saudi Arabian ancestry a juvenile-onset choreiform disease resembling HD was described, inherited as an autosomal recessive trait. The chromosomal mapping might point to 4p15.3, but still . . . [Full text of this article]




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
M. J. Friedman, C.-E. Wang, X.-J. Li, and S. Li
Polyglutamine Expansion Reduces the Association of TATA-binding Protein with DNA and Induces DNA Binding-independent Neurotoxicity
J. Biol. Chem., March 28, 2008; 283(13): 8283 - 8290.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. Hubner, A. Sprenger, C. Klein, J. Hagenah, H. Rambold, C. Zuhlke, D. Kompf, A. Rolfs, H. Kimmig, and C. Helmchen
Eye movement abnormalities in spinocerebellar ataxia type 17 (SCA17)
Neurology, September 11, 2007; 69(11): 1160 - 1168.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
S. A. Schneider, B.P.C. van de Warrenburg, T. D. Hughes, M. Davis, M. Sweeney, N. Wood, N. P. Quinn, and K. P. Bhatia
Phenotypic homogeneity of the Huntington disease-like presentation in a SCA17 family.
Neurology, November 14, 2006; 67(9): 1701 - 1703.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
K. Lasek, R. Lencer, C. Gaser, J. Hagenah, U. Walter, A. Wolters, N. Kock, S. Steinlechner, M. Nagel, C. Zuhlke, et al.
Morphological basis for the spectrum of clinical deficits in spinocerebellar ataxia 17 (SCA17)
Brain, September 1, 2006; 129(9): 2341 - 2352.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2004 by the BMJ Publishing Group Ltd.